1. Scrip
  2. >>Business

Fennec Finds Ex-US Commercial Partner For Pedmark In UK’s Norgine

 
• By Joseph Haas

Norgine will market Pedmark, indicated to reduce risk of chemotherapy-related hearing loss in pediatric cancer, in the EU and UK. It will seek additional approvals in Australia and New Zealand.

Norgine will market Fennec's hearing loss drug in the EU and elsewhere

Who: Fennec Pharmaceuticals/Norgine B.V.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business